Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression.
Oliver
R T
RT
Department of Medical Oncology, London Hospital Medical College, UK.
Tobias
J
J
Gallagher
C
C
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D018450:Disease Progression; D006133:Growth Substances / Q000009:adverse effects*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D012008:Recurrence
D018931:Antineoplastic Agents, Hormonal; D006133:Growth Substances